Ultrasound vendors Acuson and Siemens Ultrasound are the latest recipients of contracts from HMO Kaiser Permanente. After naming Acuson to be its sole provider of radiology and vascular ultrasound systems (SCAN 9/3/97), Kaiser has also named Acuson its
Ultrasound vendors Acuson and Siemens Ultrasound are the latest recipients of contracts from HMO Kaiser Permanente. After naming Acuson to be its sole provider of radiology and vascular ultrasound systems (SCAN 9/3/97), Kaiser has also named Acuson its selected vendor for cardiac ultrasound systems in adult, pediatric, intraoperative, and stress echocardiography applications.
As part of the two-year, sole-source agreement, Kaiser will buy replacement and additional Sequoia C256 and Aspen echocardiography systems over the term of the contract. The agreement also includes two single-year extension options, according to Mountain View, CA-based Acuson. Kaiser's previous preferred vendor for cardiac ultrasound was Hewlett-Packard.
In another Kaiser contract, the HMO awarded Siemens Ultrasound a two-year agreement to be its sole provider of ob/gyn, emergency-room, and urology ultrasound scanners. Under the terms of the deal, Kaiser will purchase multiple Sonoline Prima systems. The contract is valued at $1 million per year, according to the Issaquah, WA-based firm.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.